Matrix Metalloproteinase-14 Mediates a Phenotypic Shift in the Airways to Increase Mucin Production
- 1 November 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 180 (9) , 834-845
Abstract
Rationale: Induced mainly by cigarette smoking, chronic obstructive pulmonary disease (COPD) is a global public health problem characterized by progressive difficulty in breathing and increased mucin production. Previously, we reported that acrolein levels found in COPD sputum could activate matrix metalloproteinase-9 (MMP9). Objectives: To determine whether acrolein increases expression and activity of MMP14, a critical membrane-bound endopeptidase that can initial a MMP-activation cascade. Methods: MMP14 activity and adduct formation were measured following direct acrolein treatment. MMP14 expression and activity was measured in human airway epithelial cells. MMP14 immunohistochemistry was performed with COPD tissue, and in acrolein- or tobacco-exposed mice. Measurements and Main Results: In a cell-free system, acrolein, in concentrations equal to those found in COPD sputum, directly adducted cysteine 319 in the MMP14 hemopexin-like domain and activated MMP14. In cells, acrolein increased MMP14 activity, which was inhibited by a proprotein convertase inhibitor, hexa-d-arginine. In the airway epithelium of COPD subjects, immunoreactive MMP14 protein increased. In mouse lung, acrolein or tobacco smoke increased lung MMP14 activity and protein. In cells, acrolein-induced MMP14 transcripts were inhibited by an epidermal growth factor receptor (EGFR) neutralizing antibody, EGFR kinase inhibitor, metalloproteinase inhibitor, or mitogen-activated protein kinase (MAPK) 3/2 or MAPK8 inhibitors, but not a MAPK14 inhibitor. Decreasing the MMP14 protein and activity in vitro by small interfering (si)RNA to MMP14 diminished the acrolein-induced MUC5AC transcripts. In acrolein-exposed mice or transgenic mice with lung-specific transforming growth factor-α (an EGFR ligand) expression, lung MMP14 and MUC5AC levels increased and these effects were inhibited by a EGFR inhibitor, erlotinib. Conclusions: Taken together, these findings implicate acrolein-induced MMP14 expression and activity in mucin production in COPD.Keywords
Funding Information
- National Institutes of Health (ES006096)
- National Institutes of Health (ES010562)
- National Institutes of Health (ES015036)
- National Institutes of Health (ES015675)
- National Institutes of Health (HL058795)
- National Institutes of Health (HL065213)
- National Institutes of Health (HL065612)
- National Institutes of Health (HL077763)
- National Institutes of Health (HL081270)
- National Institutes of Health (HL085655)
- National Institutes of Health (HL086598)
- National Institutes of Health (HL091938)
This publication has 98 references indexed in Scilit:
- Role of endoplasmic reticulum stress in acrolein-induced endothelial activationToxicology and Applied Pharmacology, 2009
- Animal models of chronic obstructive pulmonary diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Cigarette smoke–induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodentsJournal of Clinical Investigation, 2008
- Acrolein-Activated Matrix Metalloproteinase 9 Contributes to Persistent Mucin ProductionAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and diseaseMolecular Nutrition & Food Research, 2008
- Genomic Profile of Matrix and Vasculature Remodeling in TGF-α–Induced Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Cigarette Smoke Stimulates Matrix Metalloproteinase-2 Activity via EGR-1 in Human Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Mucin Granule Intraluminal OrganizationAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repairProceedings of the National Academy of Sciences, 2006
- MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2American Journal of Physiology-Cell Physiology, 2005